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Abstract 
RNA interference has frequently been applied to modulate gene function in organisms. With the 
aim of creating new autocidal methods based on neuro-endocrine disruptors for invasive populations 
of Procambarus clarkii, we silenced the Crustacean Hyperglycemic Hormone (CHH) by injecting the 
corresponding dsRNA. CHH is a pleiotropic hormone that primarily regulates the mobilization of 
energy reserves and plays a pivotal role in stress responses. Here, we describe two experiments 
aimed at testing whether CHH silencing significantly alters important physiological aspects. The first 
experiment investigates the effects of CHH silencing at the glycemic and transcriptomic level in the 
eyestalk. The second experiment explores the long-term effects of CHH silencing and the effects on 
mortality and moulting rates. Osmotic deficits and mortality were recorded in specimens injected with 
CHH dsRNA, whilst controls were injected with GFP dsRNA. After 20 days, despite still silenced for 
CHH, individuals that survived recovered a strong hyperglycemic response after serotonin injection 
due to the compensatory effect of two peptides belonging to the crustacean neurohormone CHH 
protein family. 
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Introduction 
 
The red swamp crayfish is an invasive species 
widely distributed worldwide (ISSG, 2012). Its 
burrowing behaviour and high fertility make it very 
competitive and often winning against native 
species which inhabit the same habitat. The policies 
applied to contrast the red swamp crayfish invasion 
into new habitats so far have been unsuccessful. 
The use of autocidal methods appears to be a 
promising strategy. In fact, autocidal approaches are 
based on the target species' biology and therefore do 
not cause environmental contamination and do not 
impact non-target species (Gherardi and Angiolini, 
2004). Silencing key hormones via baits would allow 
selective disturbance of the target alien species and 
reduce adverse effects on native species, even those 
closely related to the alien species. In addition, this 
method is potentially easily applicable year round. 
The method is also relatively inexpensive, compared 
to the costs of trapping, the approach used so far to 
restrain the spreading of invasive species. 
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The crustacean hyperglycemic hormone (CHH) 
controls many fundamental physiological functions 
such as glucose mobilization from glycogen depots 
during stress responses, moulting, reproduction and 
osmoregulation (Brown, 1934; Scharrer, 1952; 
Huberman and Aguilar, 1989; De Kleijn, 1994; 
Chung and Webster, 2003; Lorenzon, 2005; 
Lorenzon et al., 2005; Katayama et al., 2013; Turner 
et al., 2013) and behavioural responses, such as 
aggression (Aquiloni et al., 2012) and anxiety (Lok 
et al., 1977). In the crayfish Pontastacus 
leptodactylus, CHH injection causes a short term 
increase in glucose levels and its reduction through 
eyestalk ablation resulted with a decrease to basal 
levels (Mosco et al., 2012, Lebaupain et al., 2012). 
Recent studies highlighted that CHH specifically 
modulates ionic and metabolic homeostasis in the 
blue crab Discoplax celeste (Turner et al., 2013) 
and a variety of other functions involving, for 
example, inhibition of ecdysteroid (Chung and 
Webster, 2003), methyl farnesoate (Borst et al., 
2001) and ovarian protein synthesis (Khayat et al., 
1998; Avarre et al., 2001). Furthermore, the 
involvement of two CHHs in the production of 
primary urine and in its branchial reprocessing was 
recently demonstrated (Turner et al., 2013). CHHa 
increases Na  uptake at the gills in the very dry +
29 
 
Table 1 Experimental plans of experiment 1 and 2 
 
 
 
 
 
 
 
 
 
 
 
 
Experiment 1
Groups
GFPi G – dsGFP Ser – G* Ser – G* – X
CHHi G – dsCHH Ser – G* Ser – G* – X
Experiment 2
Groups
GFPi G – dsGFP Ser – G* X
CHHi G – dsCHH Ser – G* X
1st Day 2nd Day 4th Day
1st Day 20th Day 26th Day
 
 
G: glycemia measurement, G*: glycemia measurements after 1, 2, 4, and 8 h from the serotonin injection, dsGFP 
or dsCHH: double strand GFP or CHH injection (2.5 µg/g body weight), Ser: Serotonin injection: Experiment 1: 
1x10-8 mol/g body weight and Experiment 2: 2x10-8 mol/g body weight, X: sacrifice of specimens for eyestalk RNA 
extractions. 
 
 
 
 
(pre-wet) season and CHHb significantly increases 
Na  uptake at the gills in the wet season. 
Noteworthy, recombinant CHH induces cellular and 
humoral responses in Litopenaeus vannamei 
infected with Vibrio harveyi, resulting in a higher 
survival rate in this group compared to controls 
(
+
Wanlem et al., 2011). Recombinant CHH also 
induces CHH expression in P. clarkii hemocytes 
(Kung et al., 2013). These data suggest an immune-
related role for CHH. Serotonin (5-HT) injection 
depletes endogenous CHH peptide reserves and 
elevates glucose level both in P. leptodactylus and 
in Squilla mantis (Lorenzon et al., 2005). These 
results corroborate the held view that 5-HT has a 
strong hyperglycemic effect through CHH release 
from the medulla terminalis X organ-sinus gland 
complex (MTXO-SG), mediated by modulation of X-
organ cells electrical activity (Sáenz et al., 1997).
RNA interference (RNAi) is a very effective 
technique to inhibit expression of genes targeting 
specific sequences (Manoharan, 2003). This 
procedure has been widely applied to develop new 
therapies (Kim and Rossi, 2007; Yu et al., 2014), to 
formulate novel drugs and vaccines (Lundstrom, 
2014), to understand important and diversified 
physiological mechanisms (Denlinger and 
Armbruster, 2014; Liu et al., 2014), to control 
pathogens (Md Ali et al., 2013; Dinh et al., 2014) 
and invasive species (Bandaranayake and Yoder, 
2013; Deng et al., 2013; Wynant et al., 2014). Two 
CHHs were found in the P. clarkii’s eyestalk 
transcriptome with different expression levels. 
CHH1 resulted to be 6X more expressed than 
CHH2 (Manfrin et al., 2014). Aiming at creating new 
pest management strategies based on the use of 
autocidal molecules administered via baits, we 
decided to explore the functional aspects of 
silencing this pivotal pleiotropic neurohormone. The 
combination of CHH transcript-silencing and CHH 
peptide depletion by serotonin was expected to 
cause a decrease in glucose levels. In this study, an 
unexpected hyperglycaemia was recorded. The new 
CHH-like transcripts previously found in P. clarkii’s 
eyestalk transcriptome were up-regulated in 
eyestalks of experimental P. clarkii. It is difficult to 
explain the function and mode of action of these two 
CHHs, but the CHH depletion, along with the other 
CHH-like transcripts, could affect the survival of P. 
clarkii in autocidal-based methods. 
 
Materials and Methods 
 
Experimental designs 
Experiments were designed to evaluate 1-
short-term effects of CHH triggered by the dsCHH 
injection (Experiment 1) and 2-long-term effects of 
CHH and effect of dsCHH injection on the survival 
and moult rate of the individuals (Experiment 2). 
Experiment 1: two groups of Procambarus clarkii 
males (10 individuals per group) were used in a 
four-day time course experiment as described in 
Table 1. About 2.5 µg/g body weight of Green 
Fluorescence Protein (GFP) or Crustacean 
Hyperglycemic Hormone (CHH) double strand RNA 
were injected at the beginning of the experiment to 
crayfish of the control and treated group, 
respectively. Serotonin (5-HT) was injected (1x10-8 
mol/g body weight, Sigma-Aldrich), at day 2 and day 
4. Hemolymphatic glycemic levels were measured 
before the serotonin injections and 1, 2, 4 and 8 h 
after 5-HT injection. Mortality and moulting events 
were recorded daily. RNAs extracted from the 
eyestalks collected on the last day of experiment 
were subjected to qRT-PCR in order to prove the 
RNAi-affected CHH-silencing. Experiment 2: 10 
control P. clarkii males and 15 dsCHH RNA-injected 
males were used in a twenty-six-day experiment 
aimed at examining the long-term effects of CHH-
RNAi injections on both glycemia and survival rate. 
As described above, 2.5 µg/g body weight of GFP 
or CHH double strand RNAs were injected at the 
beginning of the experiment. Mortality was recorded 
on a daily basis for 20 days. On the 20th day 2x10-8 
mol/g body weight of serotonin were injected to 
each individual of both groups. Hemolymphatic 
glycemic levels were measured before and 1, 2, 4 
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and 8 h post serotonin injections as in experiment 1. 
The individuals' health was checked every day until 
the 26th day and on this day total RNA was 
extracted from the eyestalks of both groups. The 
plan of experiment 2 is presented in Table 1. 
 
Animal husbandry 
All the P. clarkii individuals used in this study 
were collected from a drain inside the “Bonifica del 
Brancolo” (45°46' N, 13°30' E, GO, Italy). They were 
all adults, in intermoult and at non-reproductive 
stage. Specimens were acclimatized for a week in 
120 L tanks provided with closed circuit filtered, and 
thoroughly aerated tap water at ~18 °C, and fed fish 
pellets (Sera granular, Heisenberg, Germany) three 
times a week. Each male was maintained in an 
individual cage within the same tank to preserve the 
same environmental conditions for all experimental 
specimen. 
 
Ethical note 
The following experimental procedures comply 
with the current Italian law. No specific permits were 
required for this study, as it did not involve 
endangered or protected species. Individuals were 
maintained in appropriate laboratory conditions to 
guarantee their welfare and responsiveness. After 
the experiments were completed, crayfish were 
euthanized by hypothermia. 
 
Double-strand RNA synthesis 
Specific primers amplifying a Green 
Fluorescence Protein contained in the cloning 
vector pEGFP-N1 (GenBank accession number 
U55762) and the Crustacean Hyperglycemic 
Hormone (GenBank accession number AB027291) 
were used. Both dsGFP and dsCHH primers fused 
with T7 5’-tail sequence (underlined in Table 2) 
were designed with Primer3 (Untergrasser et al., 
2012) and checked for secondary structures and 
possible hairpin formation with Oligocalc (Kibbe, 
2007). Their sequences, along with the resulting 
amplicon sizes, are reported in Table 2. Standard 
PCRs were performed by Go Taq (R) G2 DNA 
polymerase (Promega), following these thermal 
conditions: 95 °C for 2’, 35 cycles at 95 °C for 30”, 
57 °C for 30” and 72 °C for 45” with a final extension 
step at 72 °C for 5’. The resulting amplicons were 
agarose gel purified using E.Z.N.A. Gel extraction 
kit (Omega Bio Tek) and used as templates for the 
double-strand RNAs synthesized with the 
TranscriptAid T7 High Yield Transcription Kit 
(Thermo Scientific). The dsCHH RNA probe was 
designed to silence the two P. clarkii CHH genes 
CHH1 and CHH2 (Manfrin et al., 2014), both 
involved in the hyperglycemic activity stimulation. 
The double-stranded RNA codifying the Green 
Fluorescent Protein (dsRNA-GFP) has been widely 
used as non-specific control in a variety of RNA 
interference studies (RNAi) (Westenberg et al., 
2005; Ponprateep et al., 2012). 
 
Injection and hemolymph withdrawal 
Double-stranded RNAs were suspended in 
crustacean saline solution 0.5M (NaCl 14.5 g, CaCl2 
0.72 g, MgSO4 3.18 g, KCl 0.35 g, HEPES 5mM, 
NaHCO3 0.5 g at pH 7.4 in a final volume of 1.2 L) 
with a final volume of 100 µL/animal. 
 
 
 
 
Table 2 Primer sequences and their relative amplicon sizes used to synthesize double strand-specific RNAs and 
to evaluate CHH isoforms gene expression 
 
 ID primer 5’-3’ sequence Amplicon size
Set of primers 
used for dsRNA 
synthesis 
dsGFP FOR TAATACGACTCACTATAGGGCACATGAAGCAGCACGACTTC 
dsGFP REV TAATACGACTCACTATAGGGGTTCACCTTGATGCCGTTCTTC 
304 bp 
dsCHH FOR TAATACGACTCACTATAGGGTCAGCTTCCTCTCCCAAGAC  
dsCHH REV TAATACGACTCACTATAGGGTACTTGCCGACAGTTTGGAC 
302 bp 
Set of primers 
used in qRT-
PCR 
EF1-α FOR AGATCTGAAACGTGGTTTTGTT 
EF1-α REV TCAATCTTTTCCAGAAGTTCGT 
186 bp 
β-actin FOR AGGGCGTGATGGTTGGTAT 
β-actin REV CCGTGCTCAATGGGATATTT 
100 bp 
CHH FOR GCTTGACCGAGTGTGTGAAG 
CHH REV TACTTGCCGACAGTTTGGAC 
171 bp 
CHHop FOR CCGGCTCCTTCTACAAAATC 
CHHop REV AGTACGTCAACTGCCAAGGC 
65 bp 
CHHip FOR GAAACGGAATGCAGAAAAGG 
 
CHHip REV GCAGGAAAAGGTCGGATACA 
70 bp 
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Injections and hemolymph withdrawal were 
performed through the abdominal hemolymph 
sinuses. To evaluate hemolymphatic glucose 
content, hemocytes were pelleted from the sampled 
hemolymph and the serum was kept on ice for later 
glucose measurement, which was performed using 
a glucose oxidase method (glucose liquid mono 
reagent, Hospitex diagnostics, Italy). The normal 
distribution of glycemic levels was verified with a 
Shapiro-Wilk test and homogeneity of variance 
across groups was checked with a Bartlett test. The 
null hypotheses from both tests could not be 
rejected. Hence, differences of glucose levels 
among the experimental groups were tested using 
non-parametric statistics, Kruskal-Wallis rank sum 
test with post-hoc Wilcoxon rank sum test pairwise 
comparisons with Bonferroni correction. Box and 
whiskers plots were drawn with the boxplot 
command of R. 
 
Gene expression level evaluation 
Total RNA from eyestalks was extracted by 
homogenization in TriReagent RNA isolation 
solution (Sigma-Aldrich) and purified with RNeasy 
MinElute Cleanup Kit (Qiagen). Reverse 
transcription and real time PCR reactions were 
accomplished by using the Go Taq R 2 step RT-
qPCR System (Promega) and the PCR 
amplifications were performed in triplicates for 
each RNA sample using the CFX96 Real-Time 
PCR detection system (Bio Rad) mounted on 
c1000 Thermal cycler (Bio-Rad) with the following 
thermal profile: 95 °C for 2’, 38 cycles at 95 °C for 
15”, 57 °C for 30” and 72 °C for 20”, and a final 
melting curve analysis from 65°C to 95°C with an 
increment of 0.5 °C every 5”. Elongation factor 1-
alpha (EF1-α) and β-actin were selected as 
candidate reference housekeeping genes. 
Amplification efficiencies were estimated by 
LinReg v12.1 (Ramakers et al., 2003). Gene 
expression stability for the references EF1-α and 
β-actin was tested considering as output the 
comprehensive ranking values derived from the 
comparison of Delta Ct (Silver et al., 2006), Best 
Keeper (Pfaffl et al., 2004), Normfinder (Andersen 
et al., 2004) and Genorm (Vandesompele et al., 
2002) software. Data were computed using the Bio 
Rad CFX Manager software (version 
3.0.1224.1015) and the statistical analysis 
performed using REST-2009 (Pfaffl et al., 2002). 
 
Survival analysis 
The effects of silencing on survival were 
assessed using the treatment as variable. Both 
exponential and Weibull parametric models with 
censoring were chosen because some individuals 
outlived the experiment. Statistical analyses were 
performed using R version 3.0.2 with library 
'survival' (R Core Team, 2013; Therneau, 2014). 
 
Results and Discussion 
 
Glycemic effects 
The amount of 5-HT to be injected in the 
animals was assayed through a pilot trial. During the 
trial we injected 1x10-8 mol/g of 5-HT and measured 
the glycemic levels in hemolymph 0, 1, 2, 4 and 8 
hours after the injection. After an h, glycemic levels 
were around 120 mg/dL, after 2 h around 160 mg/dL 
and at 4 h around 40 mg/dL (data not shown). This 
amount of 5-HT was then considered adequate to 
be injected in experimental groups, in order to 
deplete eyestalk endogenous CHH reserves, 
according to Lorenzon and colleagues (2005). In 
experiment 1, 24 h after the injection of dsRNA both 
dsCHH- and dsGFP-injected groups showed a 
hyperglicemic peak at 2 h post serotonin injection 
with a mean glycemia of 160.71 ± 9.01 mg/dL 
(dsCHH) and 135.04 ± 12.03 mg/dL (dsGFP). On 
the 4th day of the experiment the peak of glycemia 
of dsCHH-injected group was recorded at 2 h post 
serotonin injection with a mean glycemia of 79.14 ± 
12.27 mg/dL, whereas the dsGFP-injected animals 
showed a glycemic peak of 90.41 ± 15.23 mg/dL 4 h 
post serotonin injection. No significant differences 
were recorded between the 2 experimental groups 
(Fig. 1A). These results were possibly a 
consequence of the short duration of experiment 1. 
It was therefore assumed that the silencing duration 
was too short to reduce the CHH transcript level. In 
fact, the effects of dsCHH-RNA were evaluated after 
4 days from the dsRNA injection and the amount of 
5-HT was not enough to deplete the major amount 
of endogenous eyestalk CHH reserves. As a 
consequence, the duration of experiment 2 was 
expanded to 20 days and the amount of 5-HT 
injected in the 25 animals was doubled. The 
glycemic peak was recorded at 2 hours post 
serotonin-injection with a mean value of 89.54 ± 
17.57 mg/dL for the dsCHH-injected group and 
52.96 ± 16.66 mg/dL for dsGFP-injected animals 
and no significant differences were recorded (Fig. 
1B). Considering the 2 experiments together, there 
is a bias in the data collected on day 2 because the 
mean glycemia at time 0 is rather high due to the 
stress of dsRNA injection. In order to compare the 
peak at 2 hours (2 h) post serotonin injection in the 
2 experimental groups at different days we decided 
to subtract the glycemia value at time 0 to the value 
of 2 h for each animal. This mean glycemia of 
dsCHH varies significantly among day 2, 4 and 20 
(Kruskal-Wallis, p = 0.01) and on day 4 it is 
significantly lower than that on the day 2 (pairwise 
comparisons using Wilcoxon rank sum test, p = 
0.004) but no significant differences were recorded 
in mean glycemia between day 2 and 20 (Figs 1A, 
B). The means of glycemia at peak time (2 h) of 
dsGFP do not differ among day 2, 4 and 20 (Figs 
1A, B). 
 
CHH silencing 
Three individuals from each of the CHHi and 
GFPi experimental groups were used to evaluate 
CHH expression level, as well as of the above 
mentioned CHHop and CHHip genes using the 
EF1A as reference gene normalized to the GFPi 
group (Fig. 2). For both experiments, we were able 
to confirm the efficacy of the CHH1-2-RNA 
interference. However, the upregulation of CHHop 
and CHHip identified in the transcriptome of P. 
clarkii (Manfrin et al., 2014) was observed only after 
26 days of CHH1-2 silencing. 
We observed an up-regulation of CHHop (6 
times higher than the GFPi group) and a highly 
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Fig. 1 Box plots of glycemia levels recorded in both the experiment 1 (A) and experiment 2 (B). In the Time point 
axis -24 indicates withdrawal led the day before the 5-HT injection, 0 represents the withdrawal done just before 
the 5-HT injection and the others time-points are the hours when hemolymph was collected. 
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Fig. 2 Relative expression of CHH and CHH-like transcripts in eyestalks detected by qRT-PCR. CHHi: CHH 
interference group and GFPi: Green Fluorescent Protein interference for both the two experiments. The ΔΔCt 
method was applied by using GFPi group and EF1-α as calibrator samples. CHH1-2, CHHop (CHH homologous 
Procambarus) and CHHip (CHH Immune-related Procambarus). 
 
 
 
 
 
significant over-expression of CHHip (80 times 
higher than the GFPi group, p = 0.01) in the 
eyestalk of P. clarkii. A remarkable ability of 
decapods is their long-term survival rate even when 
bilaterally eyestalk-ablated. A possible explanation 
of this phenomenon is that the animals compensate 
the lack of eyestalk neuropeptides via their 
expression or the expression of peptides of the 
same family in ectopic tissues. Similarly, the ability 
to perform a normal hyperglycemic response after 
20 days of CHHs silencing followed by serotonin 
application suggests that other CHH family 
members could restore the hyperglycemia even 
when CHH1-2 are selectively silenced. Indeed, the 
induced expression of CHHop and CHHip after 20 
days of CHH1-2 silencing may be this compensating 
factor. 
Due to the relatively low sequence similarity 
between CHH1-2 and CHHop-ip we hypothesized 
that their involvement in compensating glycemia is a 
secondary function. Our results led us to suppose 
the possible involvement of CHHop-ip in the 
immune and stress responses. In fact, their up-
regulation during experiment 2 was detected only in 
the specimens that survived the dsCHH-RNA 
injection, since almost half of P. clarkii males died in 
the 10 days following the injection. 
Another important aspect is the absence of 
moulting events in both experimental groups, in 
contrast with the shedding episodes recorded in 
specimens collected from the same area, during the 
same days and maintained at the same laboratory 
conditions, but not challenged with any treatment. 
This finding is likely to be related to the stress 
triggered by the injection of double-stranded RNA. 
 
Survival analysis 
During experiment 1, 5 animals belonging to 
the dsCHH-injected group died, as well as 3 from 
the dsGFP-injected group. The higher number of 
specimens per experimental group in experiment 2 
allowed more accurate evaluation of survival rate, 
and this is presented in Figure 3. Following the 
Kaplan-Meier estimation, the fraction of subjects 
living during the time course of the experiment after 
the dsGFP or dsCHH injection was recorded, 
highlighting the higher mortality caused by the 
dsCHH injection.  
The highest mortality rate was reached 
between day 5 and 10 in the dsCHH RNA injected 
group. After 20 days from the beginning of the 
experiment, about 53 % of the specimens belonging 
to the dsCHH group and 70 % of the specimens 
from the dsGFP group were still alive. No significant 
difference was detected between the two groups, 
even though osmotic deficits were recorded only in 
individuals challenged with dsCHH RNA. 
 
 
 
 
 
Fig. 3 Survival analysis. dsCHH represents the 
group of P. clarkii specimens (15) injected with 
dsCHH-RNA and dsGFP represents the animals 
injected with dsGFP-RNA (10 individuals). + 
indicates the end of the observation and the 
presence of alive animals at this time. 
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Fig. 4 Osmotic deficit recorded in deceased P. clarkii specimens following dsCHH- injection. The detachment of 
the carapace from the first pleon tergite is visible in this picture. 
 
 
 
 
 
Specimens found deceased following the 
dsCHH injection, as documented in Figure 4, 
showed indeed a detachment of the carapace from 
the first pleon tergite, with the underlying 
membranous cuticle and epidermis becoming 
visible. This is an indication of osmotic deficit. In 
vivo experiments on shrimps (Nagabhushanam and 
Jyoti, 1977; McNamara et al., 1990) and crabs 
(Kamemoto et al., 1966; Kamemoto and Ono, 1969; 
Kato and Kamemoto, 1969; Kamemoto and Tullis, 
1972; Heit and Fingerman, 1975; Davis and 
Hagadorn, 1982) demonstrated that the eyestalk 
ligation or ablation increases water influx. Similarly, 
CHH silencing produces an increase in hemolymph 
volume, that can lead to death. 
These findings highlight the fundamental role of 
CHH in osmoregulatory processes suggesting that 
they might be controlled by a neuroendocrine 
mechanism, as already reported for other 
crustacean species (e.g., Serrano et al., 2003, 
Turner et al., 2013).
The second scenario refers to the specimens 
that were able to face the CHHs silencing, as shown 
by the glycemic levels presented in Figure 1, where 
a compensatory effect was activated. Glycemia 
increased along the time course experiment, to 
slowly decrease after 2 h from the initial 5-HT 
injection. What is responsible for the increased 
glycemic level if the two main CHHs produced in the 
eyestalks are silenced? It is our opinion that there 
are many other molecules related to the CHH family 
which were not silenced by our dsRNA probes due 
to the difference in nucleotide sequences. They may 
have compensated the lack of the known CHHs. To 
investigate this hypothesis further, we tested the 
expression level of two other CHH transcripts, 
CHHop and CHHip. After 26 days, both of them 
resulted up-regulated in the eyestalk of P. clarkii 
survived to the dsCHH-RNA treatment and 
significantly less expressed in specimens injected 
with dsGFP-RNA. 
Little is known about the possible involvement 
of the CHH-superfamily in the immune response, 
but this study represents the first analysis from this 
point of view. Silencing the main CHHs in the red 
swamp crayfish outlined two different scenarios: 1- 
death in the specimens not able to face the lacking 
of the CHH, 2- survival of P. clarkii individuals able 
to activate secondary responses involving other 
CHH-superfamily members. The modes of action 
and intermediates messengers associated to these 
pathways are still unknown, but CHH depletion, 
along with other CHH-like transcripts, could impact 
the survival of P. clarkii in autocidal-based 
methods. 
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